Pharmaceutical
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
OEM & ODM
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Tobramycin raw material Powder
Product Overview:
Tobramycin is also known as Tobramycin or Nebercin. One of the aminoglycoside antibiotics. It is produced by Streptomycestenebrarius. It's usually sulfate. The antibacterial spectrum was similar to that of gentamicin, but the antibacterial force against Pseudomonasaeruginosa was 2 to 4 times stronger, and it was also effective against gentamicin-resistant strains. The antibacterial activity against other G-bacilli is slightly inferior to gentamicin
Tobramycin raw material Powder Attributes
CAS:32986-56-4
MF:C18H37N5O9
MW:467.52
EINECS:251-322-5
Specification: 99% min Tobramycin Powder
Sample:Tobramycin Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:white
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Tobramycin raw material Powder Details
Tobramycin powder Usage and Synthesis.
It can be used to treat a variety of serious infections caused by Pseudomonas aeruginosa and other G-bacilli, but is generally not used as a drug of choice. Tobramycin, an aminoglycoside antibiotic with less clinical resistance, is used as a first-line treatment for early pulmonary infection with Pseudomonas aeruginosa.
Uses of Tobramycin.
Tobramycin is a monofactorial antibiotic containing approximately 10% nebramycin, an aminoglycoside antibiotic complex produced by Streptomyces Tenebrarius. Antibacterial. Similar to gentamicin broad-spectrum antibiotics, high activity against gram-negative bacilli.
Pharmacological action of Tobramycin.
The antibacterial action of tobramycin is similar to gentamicin and fusomycin, it is a broad spectrum antibiotic, but it has no effect on fungi. In gram-negative bacteria, the effect of tobramycin on P. aeruginosa was stronger than that of other aminoglycosides. Some strains of P. aeruginosa resistant to gentamicin were still sensitive to tobramycin. The minimum inhibitory concentration of this product against most of the pseudomonas aeruginosa is less than 1.5μg/ml, and the minimum inhibitory concentration against most of the Escherichia coli, pneumococcus, Enterobacter mirabilis, Proteus mirabilis, citrobacter and acinetobacter is less than 1.5μg/ml.
The sensitivity of Staphylococcus to tobramycin and gentamicin is roughly the same, and the minimum inhibitory concentration for most Staphylococcus aureus is less than 1μg/ml. The effect of this product on enterococcus is very weak, and its minimum inhibitory concentration is ≥25μg/ml. The minimum inhibitory concentration for pneumococcus, green streptococcus and streptococcus pyogenes was often greater than 25μg/ml. There was incomplete cross-resistance between tobramycin and gentamicin.
Product Methods of Tobramycin.
